Form 8-K - Current report:
SEC Accession No. 0001683168-26-002761
Filing Date
2026-04-09
Accepted
2026-04-09 08:30:09
Documents
12
Period of Report
2026-04-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sonoma_8k.htm   iXBRL 8-K 30705
2 MANUFACTURING AND SUPPLY AGREEMENT sonoma_ex1001.htm EX-10.1 199365
  Complete submission text file 0001683168-26-002761.txt   452198

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE snoa-20260408.xsd EX-101.SCH 3026
4 XBRL LABEL FILE snoa-20260408_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE snoa-20260408_pre.xml EX-101.PRE 22366
15 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3195
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 26849912
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)